TRV-2026-0598Version 1 · Certified
Reason for this version
Certified into the record
Canonical text (the exact bytes fingerprinted)
TRUVACE RECORD VERSION record: TRV-2026-0598 version: 1 kind: certified reason: Certified into the record timestamp: 2026-07-31T06:08:07.520899Z status: published lens: g_space sector: health headline: Quorum-sensing, microbiome interactions, and emerging artificial intelligence-assisted anti-virulence strategies in Salmonella Typhi: a critical review of translational opportunities and challenges dek: Typhoid fever, caused by Salmonella enterica subsp. enterica serovar Typhi (Salmonella Typhi), remains a significant global health challenge that is increasingly complicated by the emergence and spread of multidrug-resistant (MDR) and extensively drug-resistant strains. Growing limitations of antibiotic-centered treatment strategies have stimulated interest in anti-virulence approaches targeting bacterial regulatory networks rather than viability alone. Among these, quorum-sensing (QS), particularly the LuxS-med… gain_title: AI with multi-omics and systems-level frameworks was used to support target identification, microbial network reconstruction, biomarker discovery, and therapeutic prioritization for anti-virulence strategies against Salmonella Typhi. problem_title: (none) trace_subject: (none) gain_reading: AI with multi-omics and systems-level frameworks was used to support target identification, microbial network reconstruction, biomarker discovery, and therapeutic prioritization for anti-virulence strategies against Salmonella Typhi. gain_evidence: role of artificial intelligence (AI), multi-omics integration, and systems-level analytical frameworks in target identification, microbial network reconstruction, biomarker discovery, and therapeutic prioritization problem_reading: (none) problem_evidence: (none) quick_read: This critical review from July 30 2026 examines quorum-sensing, particularly LuxS-mediated AI-2 signaling, in Salmonella Typhi as a regulator of virulence, biofilm formation, and persistence amid rising multidrug-resistant and extensively drug-resistant typhoid. It surveys microbiome interactions and a range of anti-QS strategies and evaluates the role of AI, multi-omics integration, and systems-level frameworks in target identification and therapeutic prioritization. The health relevance is that QS-targeted approaches could complement antibiotics and vaccines for typhoid control, but the review finds they remain investigational. Uncertainty remains about in vivo efficacy in S. Typhi specifically, clinically validated biomarkers, microbiome variability, ecological safety, and delivery and regulatory pathways, which limits near-term translation. limitation: Evidence for QS-targeted interventions in S. Typhi is predominantly investigational with limited in vivo validation and insufficient mechanistic evidence specific to S. Typhi, plus lack of clinically validated biomarkers and concerns about microbiome variability and delivery. tag: Evidence-backed gain key_points: Typhoid fever remains complicated by multidrug-resistant and extensively drug-resistant Salmonella Typhi strains. | Review focuses on LuxS-mediated autoinducer-2 quorum-sensing regulation of virulence, biofilm formation, and persistence. | Assessed interventions include microbiome-mediated quorum quenching, probiotics, phytochemicals, signal-degrading enzymes, and nucleic acid-based approaches. | AI and multi-omics integration were examined for target identification and microbial network reconstruction. rundown: The review distinguishes experimentally validated findings in S. Typhi from evidence extrapolated from non-typhoidal Salmonella and other enteric bacteria, and examines ecological interplay between QS, gut microbiome dynamics, and host responses affecting colonization resistance. It comparatively assesses emerging anti-QS approaches including probiotics, postbiotics, phytochemicals, antimicrobial peptides, bacteriophage-associated approaches, and signal-degrading enzymes for mechanisms, evidence strength, and translational readiness as of July 30 2026. sources: - peer_reviewed | Archives of Microbiology | https://doi.org/10.1007/s00203-026-05085-0 | 2026-07-30 prev: 0000000000000000000000000000000000000000000000000000000000000000
- sha256
- d881a6fad141945fbb97089e9443e7305b853640d681201a4542118e1466a53c
- previous
- 0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-0598 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace